OR WAIT null SECS
April 05, 2023
Sartorius’ acquisition of Polyplus is designed to strengthen its cell and gene therapy capabilities.
April 02, 2023
New child-friendly treatment options and initiatives are improving the outlook of children living with HIV in Europe.
What can we take away from Pfifzer's acquisition of Seagen?
Direct-to-consumer drug advertising has developed as a cottage industry which has been used to increase prescriptions immensely.
March 30, 2023
CDMO Exothera and biotech company Remedium are joining forces to scale up the manufacturing process for Remedium’s lead gene therapy candidate for treating osteoarthritis.
Takeda plans to build a new facility in Osaka, Japan, for the manufacture of plasma-derived therapies.
The Supreme Court heard oral arguments concerning the legitimacy of “genus clauses” in bio/pharma patents.
March 27, 2023
Stephen Houldsworth, VP and Head of Platform Management & Marketing at CordenPharma, dives into ongoing trends in the outsourcing space.
Ingredion has completed two strategic investments in India with Amishi Drugs & Chemicals and Mannitab Pharma Specialties.
March 24, 2023
Harm Reduction Therapeutics and Catalent have signed a commercial supply agreement for naloxone nasal spray to reverse opioid overdoses.